Financials

  • Market Capitalization 263.38 M
  • Employee 23
  • Founded 2007
  • CEO N/A
  • Website www.whitehawktx.com
  • Headquarter Delaware, United States
  • FIGI BBG002WN7DT2
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-7.33
Price to sales ratio
20.96

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3427
SION
Sionna Therapeutics, Inc. - Common Stock
5.87 USD-3.14%+11.17%-86.87%-85.08%265.40 M USD
3431
SRZN
Surrozen, Inc. - Common Stock
22.42 USD-6.62%-4.39%+16.47%+86.37%263.51 M USD
3436
MGNX
MacroGenics, Inc. - Common Stock
4.13 USD+1.23%+1.47%+10.13%+133.33%263.08 M USD
3440
ALEC
Alector, Inc. - Common Stock
2.34 USD-2.09%-0.85%+53.95%+1.74%261.28 M USD

Frequently asked questions about Whitehawk Therapeutics, Inc. Common Stock

What is the Whitehawk Therapeutics, Inc. Common Stock stock price today?

The current price of Whitehawk Therapeutics, Inc. Common Stock (WHWK) is 4.62. Over the past 24 hours, the stock has changed by -5.13%. Follow the WHWK chart for real-time price dynamics.

What is the stock ticker of Whitehawk Therapeutics, Inc. Common Stock?

Whitehawk Therapeutics, Inc. Common Stock trades under the ticker WHWK. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Whitehawk Therapeutics, Inc. Common Stock stock going up?

WHWK has changed by -2.53% over the last week, +25.54% over the last month, and +53.49% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Whitehawk Therapeutics, Inc. Common Stock?

Whitehawk Therapeutics, Inc. Common Stock currently has a market capitalization of 263.38 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Whitehawk Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Whitehawk Therapeutics, Inc. Common Stock reported earnings of -0.2 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Whitehawk Therapeutics, Inc. Common Stock revenue for the last quarter?

Whitehawk Therapeutics, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Whitehawk Therapeutics, Inc. Common Stock net income for the last quarter?

Whitehawk Therapeutics, Inc. Common Stock reported net income of -16.64 M for the last quarter. The previous quarter showed -22.19 M, which means net income changed by +25.02%.

How many employees does Whitehawk Therapeutics, Inc. Common Stock have?

As of the latest available data, Whitehawk Therapeutics, Inc. Common Stock has 23 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Whitehawk Therapeutics, Inc. Common Stock stock?

You can buy Whitehawk Therapeutics, Inc. Common Stock (WHWK) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Whitehawk Therapeutics, Inc. Common Stock stock?

Investing in Whitehawk Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the WHWK chart and related analysis on metatrader.com as part of your research.